- (1 other version)The promise and perils of industry‐funded science.Bennett Holman & Kevin C. Elliott - 2018 - Philosophy Compass 13 (11).details
|
|
(1 other version)Understanding Pharmaceutical Research Manipulation in the Context of Accounting Manipulation.Abigail Brown - 2013 - Journal of Law, Medicine and Ethics 41 (3):611-619.details
|
|
(1 other version)Drug Firms, the Codification of Diagnostic Categories, and Bias in Clinical Guidelines.Lisa Cosgrove & Emily E. Wheeler - 2013 - Journal of Law, Medicine and Ethics 41 (3):644-653.details
|
|
(1 other version)From Community to Commodity: The Ethics of Pharma‐Funded Social Networking Sites for Physicians.Amy Snow Landa & Carl Elliott - 2013 - Journal of Law, Medicine and Ethics 41 (3):673-679.details
|
|
(1 other version)Drug Firms, the Codification of Diagnostic Categories, and Bias in Clinical Guidelines.Lisa Cosgrove & Emily E. Wheeler - 2013 - Journal of Law, Medicine and Ethics 41 (3):644-653.details
|
|
Patients' participation in decision‐making in the medical field – ‘projectification’ of patients in a neoliberal framed healthcare system.Stinne Glasdam, Christine Oeye & Lars Thrysoee - 2015 - Nursing Philosophy 16 (4):226-238.details
|
|
Medical necessity under weak evidence and little or perverse regulatory gatekeeping.John P. A. Ioannidis - 2023 - Clinical Ethics 18 (3):330-334.details
|
|
Status, Respect, and Stigma: A Qualitative Study of Non-financial Interests in Medicine.Miriam Wiersma, Ian Kerridge & Wendy Lipworth - 2020 - Journal of Bioethical Inquiry 17 (2):203-216.details
|
|
(1 other version)The ICMJE Recommendations and pharmaceutical marketing – strengths, weaknesses and the unsolved problem of attribution in publication ethics.Alastair Matheson - 2016 - BMC Medical Ethics 17 (1):1-10.details
|
|
(1 other version)Physicians under the Influence: Social Psychology and Industry Marketing Strategies.Sunita Sah & Adriane Fugh-Berman - 2013 - Journal of Law, Medicine and Ethics 41 (3):665-672.details
|
|
(1 other version)Trust and Transparency: Patient Perceptions of Physicians' Financial Relationships with Pharmaceutical Companies.Joshua E. Perry, Dena Cox & Anthony D. Cox - 2014 - Journal of Law, Medicine and Ethics 42 (4):475-491.details
|
|
(1 other version)Rooting Out Institutional Corruption to Manage Inappropriate Off‐Label Drug Use.Marc A. Rodwin - 2013 - Journal of Law, Medicine and Ethics 41 (3):654-664.details
|
|
(1 other version)From Community to Commodity: The Ethics of Pharma-Funded Social Networking Sites for Physicians.Amy Snow Landa & Carl Elliott - 2013 - Journal of Law, Medicine and Ethics 41 (3):673-679.details
|
|
Scientism in Medical Education and the Improvement of Medical Care: Opioids, Competencies, and Social Accountability.Lynette Reid - 2018 - Health Care Analysis 26 (2):155-170.details
|
|
(1 other version)Physicians under the Influence: Social Psychology and Industry Marketing Strategies.Sunita Sah & Adriane Fugh-Berman - 2013 - Journal of Law, Medicine and Ethics 41 (3):665-672.details
|
|
(1 other version)Trust and Transparency: Patient Perceptions of Physicians' Financial Relationships with Pharmaceutical Companies.Joshua E. Perry, Dena Cox & Anthony D. Cox - 2014 - Journal of Law, Medicine and Ethics 42 (4):475-491.details
|
|
(1 other version)Rooting Out Institutional Corruption to Manage Inappropriate Off-Label Drug Use.Marc A. Rodwin - 2013 - Journal of Law, Medicine and Ethics 41 (3):654-664.details
|
|
(1 other version)From Bad Pharma to Good Pharma: Aligning Market Forces with Good and Trustworthy Practices through Accreditation, Certification, and Rating.Jennifer E. Miller - 2013 - Journal of Law, Medicine and Ethics 41 (3):601-610.details
|
|
Institutional Corruption and the Pharmaceutical Policy.Marc A. Rodwin - 2013 - Journal of Law, Medicine and Ethics 41 (3):544-552.details
|
|
(1 other version)Understanding Pharmaceutical Research Manipulation in the Context of Accounting Manipulation.Abigail Brown - 2013 - Journal of Law, Medicine and Ethics 41 (3):611-619.details
|
|
Dangers of neglecting non-financial conflicts of interest in health and medicine.Miriam Wiersma, Ian Kerridge & Wendy Lipworth - 2018 - Journal of Medical Ethics 44 (5):319-322.details
|
|
(1 other version)From Bad Pharma to Good Pharma: Aligning Market Forces with Good and Trustworthy Practices through Accreditation, Certification, and Rating.Jennifer E. Miller - 2013 - Journal of Law, Medicine and Ethics 41 (3):601-610.details
|
|